- Update 05 June 2020
India expands use of controversial drug for coronavirus despite safety concerns
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Updates & Corrections
Update 05 June 2020: This article was updated to note the retraction of a study suggesting that hydroxychloroquine might be dangerous to patients with COVID-19.
Mehra, M. R., Desai, S. S., Ruschitzka, F. & Patel, A. N. Lancet https://doi.org/10.1016/S0140-6736(20)31180-6 (2020).
Chatterjee, P. et al. Indian J. Med. Res. https://doi.org/10.4103/ijmr.IJMR_2234_20 (2020).